Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $8.60 Average Price Target from Analysts
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price target among […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price target among […]
